Our analysis indicated that anti PD-1 therapy is associated with fewer adverse events than docetaxel treatment, which is in accordance with previous reports about grade 1-4 nausea, febrile neutropenia, diarrhea, anemia, neutropenia, fatigue and alopecia. This evidence concerns the gene PDCD1 and anemia (phenotype).